Microlife Microlife
  • Prodotti Domiciliari
    • BP A6 Advanced Easy_red_logo Pressione arteriosa
    • trasp_NON CONTACT Febbre
    • trasp_NEB NANO_half-acc_PRINT_LOcopy1 Terapia respiratoria
    • trasp_WS 80n_half Controllo del peso
    • Software_downloads_allg Software
  • Prodotti Professionali
    • WatchBP Office ABI_front_cuff WatchBP Office
    • WatchBP O3 Ambulatory AFIB_front_cuff WatchBP 03
    • WatchBP Home A_front_cuff WatchBP Home
    • Cuff-Ankle Bracciali e Accessori
    • Software Software
  • Tecnologie
  • Magazine
  • Azienda
    • aboutus Chi siamo
    • Events Eventi e News
    • contact Contatti
    • History Storia
ITALIA
Italiano
Europe
  • EUROPE - English
  • CZECHIA - Čeština
  • DANMARK - Dansk
  • DEUTSCHLAND - Deutsch
  • ESPAÑA - Español
  • FRANCE - Français
  • HRVATSKA - Hrvatski
  • ITALIA - Italiano
  • LATVIJA - Latviešu
  • LIETUVA - Lietuvių
  • MAGYARORSZÁG - Magyar
  • NEDERLAND - Nederlands
  • ÖSTERREICH - Deutsch
  • POLSKA - Polski
  • PORTUGAL - Português
  • SCHWEIZ - Deutsch
  • SLOVENSKO - Slovenčina
  • SLOVENIJA - Slovenščina
  • SUOMI - Suomi
  • SCHWEIZ - Français
  • UK - English
  • ΕΛΛΆΔΑ - Ελληνικά
  • БЪЛГАРИЯ - Български
  • СРБИЈА - Српски
  • УКРАЇНА - Українська
  • TÜRKIYE - Türkçe
  • РОССИЯ - Русский
  • БЕЛАРУСЬ - Русский
Asia
  • ASIA PACIFIC - English
  • VIỆT NAM - Tiếng Việt
  • ประเทศไทย - ไทย
  • 中国 - 中文
  • 台灣 - 中文
Middle East and North Africa
  • MENA - Arabic عربى
USA, Latin America
  • US - English
  • AMÉRICA DEL SUR - Español
  • COLOMBIA - Español
  • MÉXICO - Español
Menu
Header Microlife & WatchBP Clinical Studies Flow

Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors

Home > Prodotti Professionali
Share

2014, Karen Kearley, Mary Selwood, Ann Van den Bruel, Matthew Thompson, David Mant, FD Richard Hobbs, David Fitzmaurice, Carl Heneghan

Abstract

Objective:
New electronic devices offer an opportunity within routine primary care settings for improving the detection of atrial fibrillation (AF), which is a common cardiac arrhythmia and a modifiable risk factor for stroke. We aimed to assess the performance of a modified blood pressure (BP) monitor and two singlelead ECG devices, as diagnostic triage tests for the detection of AF.

Setting:
6 General Practices in the UK.

Participants:
1000 ambulatory patients aged 75 years and over.

Primary and secondary outcome measures:
Comparative diagnostic accuracy of modified BP monitor and single-lead ECG devices, compared to reference standard of 12-lead ECG, independently interpreted by cardiologists. 

Results:
A total of 79 participants (7.9%) had AF diagnosed by 12-lead ECG. All three devices had a high sensitivity (93.9–98.7%) and are useful for ruling out AF. WatchBP is a better triage test than Omron autoanalysis because it is more specific—89.7% (95% CI 87.5% to 91.6%) compared to 78.3% (95% CI 73.0% to 82.9%), respectively. This would translate into a lower follow-on ECG rate of 17% to rule in/rule out AF compared to 29.7% with the Omron text message in the study population. The overall specificity of single-lead ECGs analysed by a cardiologist was 94.6% for Omron and 90.1% for Merlin.

Conclusions:
WatchBP performs better as a triage test for identifying AF in primary care than the singlelead ECG monitors as it does not require expertise for interpretation and its diagnostic performance is comparable to single-lead ECG analysis by cardiologists. It could be used opportunistically to screen elderly patients for undiagnosed AF at regular intervals and/or during BP measurement.

Download Abstract as PDF-file

Microlife
  • Contatti
  • Sede Legale
  • Privacy & Cookie Policy
  • Termini di utilizzo
  • Sviluppatori
Login
Copyright © 2025 - Microlife Corporation. All rights reserved.